Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 15,776,000 | 15,423,000 | 13,343,000 | 15,102,000 | 14,460,000 |
| Cost of Goods | 5,304,000 | 4,346,000 | 4,002,000 | 4,396,000 | 4,212,000 |
| Gross Profit | 10,472,000 | 11,077,000 | 9,341,000 | 10,706,000 | 10,248,000 |
| Operating Expenses | 8,568,000 | 6,183,000 | 5,608,000 | 12,196,000 | 6,417,000 |
| Operating Income | 1,904,000 | 4,894,000 | 3,733,000 | -1,490,000 | 3,831,000 |
| Interest Expense | 667,000 | 678,000 | 627,000 | 610,000 | 591,000 |
| Other Income | -523,000 | -2,662,000 | -1,445,000 | -169,000 | -1,156,000 |
| Pre-tax Income | 714,000 | 1,554,000 | 1,661,000 | -2,269,000 | 2,084,000 |
| Income Tax | 526,000 | 613,000 | 372,000 | -2,246,000 | 520,000 |
| Net Income Continuous | 188,000 | 941,000 | 1,289,000 | -23,000 | 1,564,000 |
| Minority Interests | 2,000 | 3,000 | 3,000 | -1,000 | 3,000 |
| Net Income | $186,000 | $938,000 | $1,286,000 | $-22,000 | $1,561,000 |
| EPS Basic Total Ops | 0.10 | 0.52 | 0.72 | -0.02 | 0.88 |
| EPS Basic Continuous Ops | 0.11 | 0.53 | 0.73 | -0.01 | 0.88 |
| EPS Diluted Total Ops | 0.10 | 0.52 | 0.72 | -0.03 | 0.88 |
| EPS Diluted Continuous Ops | 0.11 | 0.53 | 0.73 | -0.01 | 0.88 |
| EPS Diluted Before Non-Recurring Items | 1.86 | 2.97 | 2.46 | 2.16 | 3.00 |
| EBITDA(a) | $4,814,000 | $6,944,000 | $5,772,000 | $612,000 | $5,910,000 |